First Published Study to Report In Vitro Detection of Fluorescence from Bacteria in Biofilm with Point-of-care Wound Imaging Device

March 3, 2020 -In Vitro Study Demonstrates Detectable Red Fluorescence from 88% of Planktonic and Biofilm Wound Pathogens when Imaged by the MolecuLight i:X® Imaging Device

Toronto, CANADA – (March 3, 2020) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, announces the publication of  “… Read More

New MolecuLight i:X® Upgrade Enables Faster, More Accurate Digital Wound Measurement

February 20, 2020 -i:X Platform’s Precise Wound Measurement, along with Fluorescence Imaging, for More Accurate Detection and Ongoing Documentation of Wounds

Toronto, CANADA – (February 20, 2020) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, released a significant upgrade to its i:X digital wound measurement

American Medical Association Issues Category lll CPT Code for Real-time Fluorescence Wound Imaging

February 13, 2020 -

Reimbursement Pathway Established for MolecuLight’s i:X Procedure in Wound Care

TORONTO, Canada – (February 13, 2020) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, announced that the American Medical Association (AMA) has issued two new CPT category lll codes to enable a

University Hospitals Ahuja Medical Center Physician First in Ohio to Use Wound Care Imaging Device in Clinical Setting

February 11, 2020 -

Portable MolecuLight i:X allows for imaging of harmful bacteria invisible to human eye

University Hospitals Ahuja Medical Center (UH) is the first clinical setting in Ohio using special technology to identify harmful bacteria, leading to healing for patients suffering from chronic wounds.

Windy Cole, DPM, Medical Director of the UH